Novavax COVID vaccine backed for authorization by U.S. FDA panel

Novavax COVID vaccine backed for authorization by U.S. FDA panel Advisers to the U.S. Food and Drug Administration on Tuesday voted overwhelmingly to recommend that the agency authorize Novavax Inc's COVID-19 vaccine for use in adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics. Michael Erman,Manas Mishra Reuters

...

Novavax's shot is a more traditional type of vaccine employing technology that has been used for decades to combat diseases including Hepatitis B and influenza...